The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan)

Abstract We examined the impact of starting treatment on clinical outcomes in men with metastatic castration-sensitive prostate cancer (mCSPC). This retrospective observational cohort study used claims data from the Medical Data Vision (MDV) hospital-based administrative dataset in Japan. All patien...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Masaki Shiota, Yanfang Liu, Suneel Mundle, Mehregan Nematian-Samani, Jason Hwang, Xiayi Wang, Hirotsugu Uemura
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-04-01
coleção:	Scientific Reports
Assuntos:	Androgen receptor signalling inhibitors Apalutamide Metastatic castration-sensitive prostate cancer Overall survival
Acesso em linha:	https://doi.org/10.1038/s41598-025-93136-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!